Diabetes Drugmakers Get Pancreatic Most cancers Lawsuits Thrown Out


Eli Lilly & Co., Merck Sharp & Dohme Corp., Novo Nordisk Inc., and Amylin Pharmaceuticals LLC have won dismissal of hundreds of lawsuits related to diabetes medication causing pancreatic cancer, a federal court in California said federal law upheld the claims Plaintiff given priority.

Lilly and the others could not have warned plaintiffs’ pancreatic cancer without violating federal drug labeling law, said Judge Anthony J. Battaglia of the U.S. District Court for the Southern District of California.

The brand name drugs in question are of a type known as incretin mimetics. They are Janumet and Januvia, made by Merck; …